Session 1: Translational Biotechnology & Advanced Health Frontiers (Sessão 1: Biotecnologia Translacional e Fronteiras Avançadas da Saúde)

02:00 PM: Synthetic Organic Chemistry towards Biologically Active Heterocyclic Compounds – Artur M. S. Silva (University of Aveiro, Portugal).
02:20 PM: Bacterial NanoCellulose containing natural extracts as a Framework for Disruptive Wound Care – Hernane S. Barud (Uniara & HB Biotec, Brazil).
02:40 PM: From laboratory to clinic: mesenchymal stem cells advanced therapies – Fernanda Bombaldi (R-Crio, Brazil).
03:00 PM: Learning immunologic mechanisms from genetic diseases – Fátima Macedo (University of Algarve, Portugal).
03:20 PM: Understanding the Relationship Between the Extracellular Matrix and Breast Cancer Tumor Malignancy – Maria Angelica Miglino (UNIMAR, Brazil).
03:40 PM: Afternoon Coffee Break (20 minutes)
04:00 PM: Novel Benzimidazole derivatives as-Met kinase inhibitors and its design and synthesis – Manjunath Ghate (NFSU, India).
04:20 PM: Anti-Inflammatory Potential of Rice-Infused Eleusine indica: Phytochemical Insights from Tandem LC–MS Molecular Networking – Fatimah Salim (UiTM, Malaysia).
04:40 PM: From Azorean Biodiversity to Health Innovation: Bioactive Compounds from Plant Biomass with Antidiabetic and Anti-Aging Potential – Ana M. L. Seca (Univ. Azores/Aveiro, Portugal).
05:00 PM: From Signals to Symptoms: Advances in Noninvasive Monitoring of Gastrointestinal Motility – Luciana Cora (UNCISAL, Brazil).
05:20 PM: Nanoplastics and Neurotoxicity: Implications for Sustainable Health – Chooi Ling Lim (IMU University, Malaysia).
05:40 PM: Integrated In Silico Approaches for the Design of Dual PDE1B and PDE10A Inhibitors Against Schizophrenia – Anand Gaurav (UPES, India / Villa College, Maldives / UCSI University, Malaysia).